BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 18019678)

  • 1. The effect of transgenic expression of TGF-beta1 on transplanted islet graft survival.
    Yamasaki S; Kurita N; Hata J; Moritani M; Itakura M; Shimada M
    Hepatogastroenterology; 2007 Sep; 54(78):1617-21. PubMed ID: 18019678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene transfection and expression of transforming growth factor-beta1 in nonobese diabetic mouse islets protects beta-cells in syngeneic islet grafts from autoimmune destruction.
    Suarez-Pinzon WL; Marcoux Y; Ghahary A; Rabinovitch A
    Cell Transplant; 2002; 11(6):519-28. PubMed ID: 12428741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abrogation of autoimmune diabetes in nonobese diabetic mice and protection against effector lymphocytes by transgenic paracrine TGF-beta1.
    Moritani M; Yoshimoto K; Wong SF; Tanaka C; Yamaoka T; Sano T; Komagata Y; Miyazaki J; Kikutani H; Itakura M
    J Clin Invest; 1998 Aug; 102(3):499-506. PubMed ID: 9691086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination therapy with low dose sirolimus and tacrolimus is synergistic in preventing spontaneous and recurrent autoimmune diabetes in non-obese diabetic mice.
    Shapiro AM; Suarez-Pinzon WL; Power R; Rabinovitch A
    Diabetologia; 2002 Feb; 45(2):224-30. PubMed ID: 11935154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of recurrent but not spontaneous autoimmune diabetes by transplanted NOD islets adenovirally transduced with immunomodulating molecules.
    Sakata M; Yasuda H; Moriyama H; Yamada K; Kotani R; Kurohara M; Okumachi Y; Kishi M; Arai T; Hara K; Hamada H; Yokono K; Nagata M
    Diabetes Res Clin Pract; 2008 Jun; 80(3):352-9. PubMed ID: 18400329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TNF-alpha down-regulates type 1 cytokines and prolongs survival of syngeneic islet grafts in nonobese diabetic mice.
    Rabinovitch A; Suarez-Pinzon WL; Sorensen O; Rajotte RV; Power RF
    J Immunol; 1997 Dec; 159(12):6298-303. PubMed ID: 9550435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Islet mass plays a critical role in initiation, but not progression, of the diabetogenic process in NOD mice.
    Kimura T; Ito A; Hancock WW; Maki T
    J Autoimmun; 1999 Jun; 12(4):243-9. PubMed ID: 10330295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term islet allograft survival in nonobese diabetic mice treated with tacrolimus, rapamycin, and anti-interleukin-2 antibody.
    Molano RD; Pileggi A; Berney T; Poggioli R; Zahr E; Oliver R; Malek TR; Ricordi C; Inverardi L
    Transplantation; 2003 Jun; 75(11):1812-9. PubMed ID: 12811239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local expression of immunoregulatory IL-12p40 gene prolonged syngeneic islet graft survival in diabetic NOD mice.
    Yasuda H; Nagata M; Arisawa K; Yoshida R; Fujihira K; Okamoto N; Moriyama H; Miki M; Saito I; Hamada H; Yokono K; Kasuga M
    J Clin Invest; 1998 Nov; 102(10):1807-14. PubMed ID: 9819366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion of STAT-1 pancreatic islets protects against streptozotocin-induced diabetes and early graft failure but not against late rejection.
    Callewaert HI; Gysemans CA; Ladrière L; D'Hertog W; Hagenbrock J; Overbergh L; Eizirik DL; Mathieu C
    Diabetes; 2007 Aug; 56(8):2169-73. PubMed ID: 17473223
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abrogation of recurrent autoimmunity in the NOD mouse: A critical role for host interleukin 4.
    Shi Q; Wang D; Hadley GA; Farber DL; Bartlett ST
    Surgery; 2006 Aug; 140(2):281-8. PubMed ID: 16904981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indefinite islet protection from autoimmune destruction in nonobese diabetic mice by agarose microencapsulation without immunosuppression.
    Kobayashi T; Aomatsu Y; Iwata H; Kin T; Kanehiro H; Hisanaga M; Ko S; Nagao M; Nakajima Y
    Transplantation; 2003 Mar; 75(5):619-25. PubMed ID: 12640299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of donor immune cells in pancreatic islet transplantation.
    Carter JD; Chen M; Ellett JD; Smith KM; Nadler JL; Yang Z
    Transplant Proc; 2004 Nov; 36(9):2866-8. PubMed ID: 15621170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of simultaneous CD154 and LFA-1 blockade on the survival of allogeneic islet grafts in nonobese diabetic mice.
    Berney T; Pileggi A; Molano RD; Poggioli R; Zahr E; Ricordi C; Inverardi L
    Transplantation; 2003 Dec; 76(12):1669-74. PubMed ID: 14688513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of hyperglycemia on the primary function of allogeneic islet transplants.
    Makhlouf L; Duvivier-Kali VF; Bonner-Weir S; Dieperink H; Weir GC; Sayegh MH
    Transplantation; 2003 Aug; 76(4):657-64. PubMed ID: 12973104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse.
    Nanji SA; Hancock WW; Luo B; Schur CD; Pawlick RL; Zhu LF; Anderson CC; Shapiro AM
    Diabetes; 2006 Jan; 55(1):27-33. PubMed ID: 16380473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoplasia of endocrine and exocrine pancreas in homozygous transgenic TGF-beta1.
    Moritani M; Yamasaki S; Kagami M; Suzuki T; Yamaoka T; Sano T; Hata J; Itakura M
    Mol Cell Endocrinol; 2005 Jan; 229(1-2):175-84. PubMed ID: 15607541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination therapy with epidermal growth factor and gastrin delays autoimmune diabetes recurrence in nonobese diabetic mice transplanted with syngeneic islets.
    Suarez-Pinzon WL; Rabinovitch A
    Transplant Proc; 2008 Mar; 40(2):529-32. PubMed ID: 18374121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testicular sertoli cells protect islet beta-cells from autoimmune destruction in NOD mice by a transforming growth factor-beta1-dependent mechanism.
    Suarez-Pinzon W; Korbutt GS; Power R; Hooton J; Rajotte RV; Rabinovitch A
    Diabetes; 2000 Nov; 49(11):1810-8. PubMed ID: 11078447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rejection of human islets and human HLA-A2.1 transgenic mouse islets by alloreactive human lymphocytes in immunodeficient NOD-scid and NOD-Rag1(null)Prf1(null) mice.
    Banuelos SJ; Shultz LD; Greiner DL; Burzenski LM; Gott B; Lyons BL; Rossini AA; Appel MC
    Clin Immunol; 2004 Sep; 112(3):273-83. PubMed ID: 15308121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.